Cardiac Arrhythmias in COVID-19 Infection.
作者信息
Kochav Stephanie M, Coromilas Ellie, Nalbandian Ani, Ranard Lauren S, Gupta Aakriti, Chung Mina K, Gopinathannair Rakesh, Biviano Angelo B, Garan Hasan, Wan Elaine Y
机构信息
Division of Cardiology, Department of Medicine, Columbia University Vagelos College of Physicians and Surgeons, New York, NY (S.M.K., E.C., A.N., L.S.R., A.G., A.B.B., H.G., E.Y.W.).
Heart, Vascular, and Thoracic Institute and Lerner Research Institute, Cleveland Clinic, OH (M.K.C.).
出版信息
Circ Arrhythm Electrophysiol. 2020 Jun;13(6):e008719. doi: 10.1161/CIRCEP.120.008719. Epub 2020 May 20.
Abstract
摘要
相似文献
1
Cardiac Arrhythmias in COVID-19 Infection.新型冠状病毒肺炎感染中的心律失常
Circ Arrhythm Electrophysiol. 2020 Jun;13(6):e008719. doi: 10.1161/CIRCEP.120.008719. Epub 2020 May 20.
2
Atrial Arrhythmias in a Patient Presenting With Coronavirus Disease-2019 (COVID-19) Infection.一名新型冠状病毒肺炎（COVID-19）感染患者的房性心律失常
J Investig Med High Impact Case Rep. 2020 Jan-Dec;8:2324709620925571. doi: 10.1177/2324709620925571.
3
The QT interval in patients with COVID-19 treated with hydroxychloroquine and azithromycin.接受羟氯喹和阿奇霉素治疗的新冠肺炎患者的QT间期。
Nat Med. 2020 Jun;26(6):808-809. doi: 10.1038/s41591-020-0888-2.
4
Noteworthy Electrocardiographic Changes Following Pharmacologic Treatment of COVID-19.新型冠状病毒肺炎药物治疗后的显著心电图变化
Am J Crit Care. 2020 Sep 1;29(5):407-408. doi: 10.4037/ajcc2020779.
5
Use of drugs with potential cardiac effect in the setting of SARS-CoV-2 infection.在新型冠状病毒2019感染的情况下使用具有潜在心脏效应的药物。
Arch Cardiovasc Dis. 2020 May;113(5):293-296. doi: 10.1016/j.acvd.2020.04.003. Epub 2020 Apr 24.
6
Guillain-Barré syndrome related to COVID-19 infection.与新型冠状病毒肺炎感染相关的吉兰-巴雷综合征
Neurol Neuroimmunol Neuroinflamm. 2020 Apr 29;7(4). doi: 10.1212/NXI.0000000000000741. Print 2020 Jul.
7
SARS-CoV-2 pulmonary infection revealed by subcutaneous emphysema and pneumomediastinum.皮下气肿和纵隔气肿提示的新型冠状病毒肺炎感染
Intensive Care Med. 2020 Aug;46(8):1620-1621. doi: 10.1007/s00134-020-06078-3. Epub 2020 May 19.
8
Myocarditis in a 16-year-old boy positive for SARS-CoV-2.一名16岁SARS-CoV-2检测呈阳性男孩的心肌炎
Lancet. 2020 Jun 27;395(10242):e116. doi: 10.1016/S0140-6736(20)31307-6.
9
Enhanced electrocardiographic monitoring of patients with Coronavirus Disease 2019.强化 2019 冠状病毒疾病患者的心电图监测。
Heart Rhythm. 2020 Sep;17(9):1417-1422. doi: 10.1016/j.hrthm.2020.04.047. Epub 2020 May 6.
10
Transient complete heart block in a patient with critical COVID-19.一名重症新型冠状病毒肺炎患者出现短暂性完全性心脏传导阻滞。
Eur Heart J. 2020 Jun 7;41(22):2131. doi: 10.1093/eurheartj/ehaa307.
引用本文的文献
1
COVID-19 Predisposition Inherently Increases Cardiovascular Risk Before SARS-CoV-2 Infection.新冠病毒易感性在感染严重急性呼吸综合征冠状病毒2之前就固有地增加心血管风险。
Cardiovasc Toxicol. 2025 Jun;25(6):821-829. doi: 10.1007/s12012-025-09996-0. Epub 2025 Apr 19.
2
COVID-19 and Cardiac Arrhythmias: Lesson Learned and Dilemmas.新冠病毒肺炎与心律失常：经验教训与困境
J Clin Med. 2024 Nov 29;13(23):7259. doi: 10.3390/jcm13237259.
3
Increased interleukin-6 levels are associated with atrioventricular conduction delay in severe COVID-19 patients.白细胞介素-6水平升高与重症COVID-19患者的房室传导延迟有关。
J Arrhythm. 2024 Jul 31;40(5):1137-1148. doi: 10.1002/joa3.13114. eCollection 2024 Oct.
4
Cardiac Arrhythmias and Autonomic Dysfunction Associated With COVID-19: A Scientific Statement From the American Heart Association.与 COVID-19 相关的心律失常和自主神经功能障碍：美国心脏协会的科学声明。
Circulation. 2024 Nov 19;150(21):e449-e465. doi: 10.1161/CIR.0000000000001290. Epub 2024 Oct 14.
5
Pathogenic mechanisms of cardiovascular damage in COVID-19.COVID-19 中心血管损伤的发病机制。
Mol Med. 2024 Jun 19;30(1):92. doi: 10.1186/s10020-024-00855-2.
6
Fatal arrhythmia associated with novel coronavirus 2019 infection: Case report and literature review.新型冠状病毒 2019 感染相关致命性心律失常：病例报告及文献复习。
Medicine (Baltimore). 2024 Apr 19;103(16):e37894. doi: 10.1097/MD.0000000000037894.
7
Management of Multisystem Inflammatory Syndrome in Children Associated with COVID-19 Infection.与新冠病毒感染相关的儿童多系统炎症综合征的管理
Curr Treat Options Pediatr. 2021;7(3):119-128. doi: 10.1007/s40746-021-00224-9. Epub 2021 May 6.
8
Third-Degree Heart Block in COVID-19 Pneumonia Complicated by Methicillin-Resistant Staphylococcus Aureus (MRSA) Bacteremia. A Case Report and Review of Literature.新冠肺炎合并耐甲氧西林金黄色葡萄球菌（MRSA）菌血症导致的三度房室传导阻滞。病例报告及文献综述
J Community Hosp Intern Med Perspect. 2023 Nov 4;13(6):76-79. doi: 10.55729/2000-9666.1269. eCollection 2023.
9
Electrocardiography in Children Hospitalized for COVID-19 and Not Suffering from Multisystem Inflammatory Syndrome in Children (MIS-C): An Observational Study.因COVID-19住院且未患儿童多系统炎症综合征（MIS-C）的儿童的心电图检查：一项观察性研究
J Cardiovasc Dev Dis. 2024 Mar 4;11(3):85. doi: 10.3390/jcdd11030085.
10
Unknown adverse drug reactions from spontaneous reports in a hospital setting: characterization, follow-up, and contribution to the pharmacovigilance system.医院环境中自发报告的未知药品不良反应：特征、随访及对药物警戒系统的贡献
Front Pharmacol. 2023 Jul 10;14:1211786. doi: 10.3389/fphar.2023.1211786. eCollection 2023.
本文引用的文献
1
Urgent Guidance for Navigating and Circumventing the QTc-Prolonging and Torsadogenic Potential of Possible Pharmacotherapies for Coronavirus Disease 19 (COVID-19).急件：针对新型冠状病毒病（COVID-19）可能的药物治疗的 QTc 延长和致扭转型心动过速的潜在风险的应对和规避指导建议。
Mayo Clin Proc. 2020 Jun;95(6):1213-1221. doi: 10.1016/j.mayocp.2020.03.024. Epub 2020 Apr 7.
2
Acute myocarditis presenting as a reverse Tako-Tsubo syndrome in a patient with SARS-CoV-2 respiratory infection.一名感染严重急性呼吸综合征冠状病毒2（SARS-CoV-2）的患者出现急性心肌炎，表现为反向Tako-Tsubo综合征。
Eur Heart J. 2020 May 14;41(19):1861-1862. doi: 10.1093/eurheartj/ehaa286.
3
The Variety of Cardiovascular Presentations of COVID-19.新型冠状病毒肺炎的心血管表现多样性
Circulation. 2020 Jun 9;141(23):1930-1936. doi: 10.1161/CIRCULATIONAHA.120.047164. Epub 2020 Apr 3.
4
Guidance for Cardiac Electrophysiology During the COVID-19 Pandemic from the Heart Rhythm Society COVID-19 Task Force; Electrophysiology Section of the American College of Cardiology; and the Electrocardiography and Arrhythmias Committee of the Council on Clinical Cardiology, American Heart Association.COVID-19 大流行期间心脏节律学会 COVID-19 工作组、美国心脏病学会电生理分会以及美国心脏协会临床心脏病学理事会心电图和心律失常委员会关于心脏电生理学的指南。
Circulation. 2020 May 26;141(21):e823-e831. doi: 10.1161/CIRCULATIONAHA.120.047063. Epub 2020 Mar 31.
5
Cardiovascular Implications of Fatal Outcomes of Patients With Coronavirus Disease 2019 (COVID-19).COVID-19 患者的致命结局对心血管的影响。
JAMA Cardiol. 2020 Jul 1;5(7):811-818. doi: 10.1001/jamacardio.2020.1017.
6
Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial.羟氯喹和阿奇霉素治疗 COVID-19：一项开放标签非随机临床试验的结果。
Int J Antimicrob Agents. 2020 Jul;56(1):105949. doi: 10.1016/j.ijantimicag.2020.105949. Epub 2020 Mar 20.
7
Case-Fatality Rate and Characteristics of Patients Dying in Relation to COVID-19 in Italy.意大利新冠肺炎死亡患者的病死率及特征
JAMA. 2020 May 12;323(18):1775-1776. doi: 10.1001/jama.2020.4683.
8
Cardiovascular Considerations for Patients, Health Care Workers, and Health Systems During the COVID-19 Pandemic.心血管考虑因素在 COVID-19 大流行期间的患者、医护人员和卫生系统。
J Am Coll Cardiol. 2020 May 12;75(18):2352-2371. doi: 10.1016/j.jacc.2020.03.031. Epub 2020 Mar 19.
9
Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China.中国武汉 2019 年冠状病毒病肺炎患者急性呼吸窘迫综合征和死亡的相关危险因素。
JAMA Intern Med. 2020 Jul 1;180(7):934-943. doi: 10.1001/jamainternmed.2020.0994.
10
Chloroquine and hydroxychloroquine as available weapons to fight COVID-19.氯喹和羟氯喹作为对抗新型冠状病毒肺炎的现有武器。
Int J Antimicrob Agents. 2020 Apr;55(4):105932. doi: 10.1016/j.ijantimicag.2020.105932. Epub 2020 Mar 4.
Zotero 插件